Myelodysplastic syndromes clinical practice guidelines in oncology.
Greenberg
Peter L
PL
Stanford Hospital and Clinics, Stanford, CA, USA.
Baer
Maria R
MR
Bennett
John M
JM
Bloomfield
Clara D
CD
De Castro
Carlos M
CM
Deeg
H Joachim
HJ
Devetten
Marcel P
MP
Emanuel
Peter D
PD
Erba
Harry P
HP
Estey
Eli
E
Foran
James
J
Gore
Steven D
SD
Millenson
Michael
M
Navarro
Willlis H
WH
Nimer
Stephen D
SD
O'Donnell
Margaret R
MR
Saba
Hussain I
HI
Spiers
Kathy
K
Stone
Richard M
RM
Tallman
Martin S
MS
D000465:Algorithms; D000753:Anemia, Refractory / Q000175:diagnosis / Q000628:therapy; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D003131:Combined Modality Therapy; D017707:Erythrocyte Transfusion / Q000009:adverse effects; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015477:Leukemia, Myelomonocytic, Chronic / Q000175:diagnosis / Q000628:therapy; D009190:Myelodysplastic Syndromes / Q000175:diagnosis* / Q000628:therapy*; D016896:Treatment Outcome
D000970:Antineoplastic Agents